Effects of Personalized Cardiac Rehabilitation on miRNAs and Biochemical Biomarkers in Patients With Coronary Artery Disease
Changes in Specific miRNAs and Biochemical Biomarkers Following Personalized Cardiac Rehabilitation in Patients With Coronary Artery Disease
This prospective interventional study aims to investigate changes in specific microRNAs (miRNAs) and biochemical biomarkers following a personalized cardiac rehabilitation program in patients with coronary artery disease. A total of 46 participants aged 35-75 years who have undergone percutaneous coronary intervention or coronary artery bypass graft surgery and are eligible for cardiac rehabilitation will be included. Participants will complete a structured, individualized cardiac rehabilitation program lasting 6-8 weeks. Clinical assessments, cardiopulmonary exercise testing, and blood-based biomarker measurements will be performed before and after the rehabilitation program. The primary objective is to determine changes in miRNA and biochemical biomarker levels after cardiac rehabilitation and to evaluate the relationship between these changes and clinical improvement. The findings may contribute to a better understanding of biological responses to cardiac rehabilitation and support the development of more personalized rehabilitation strategies.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Vural KAVUNCU, Prof. Dr.
- 전화번호: 90 505 777 43 06
- 이메일: vural.kavuncu@ksbu.edu.tr
연구 연락처 백업
- 이름: Meltem ÇOBAN, Dr.
- 전화번호: +90 544 284 42 58
- 이메일: meltem.368@hotmail.com
연구 장소
-
-
-
Kütahya, 터키 (Türkiye), 43020
- Kutahya Health Sciences University
-
연락하다:
- Vural KAVUNCU, Prof. Dr.
- 전화번호: 1111 02742630043
- 이메일: vural.kavuncu@ksbu.edu.tr
-
수석 연구원:
- Fatima YAMAN, Assoc. Prof
-
수석 연구원:
- Meltem ÇOBAN, Dr.
-
부수사관:
- Merve AKDENİZ LEBLEBİCİER, Assoc. Prof
-
부수사관:
- Mevlüt DEMİR, Assoc. Prof
-
부수사관:
- Cansu OZBAYER, Prof. Dr.
-
부수사관:
- Fatih KAR, Assoc. Prof.
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Stable coronary artery disease
- History of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)
- Referred and considered clinically eligible for a structured cardiac rehabilitation program
- Achievement of a respiratory quotient (RQ) of at least 1.0 during the baseline cardiopulmonary exercise test
- Ability and willingness to participate in the study and complete the cardiac rehabilitation program
Exclusion Criteria:
- Symptoms or signs of myocardial ischemia
- Significant left ventricular outflow tract obstruction
- Ventricular arrhythmia
- Significant valvular heart disease
- Uncontrolled hypertension
- Severe comorbid conditions, including end-stage renal disease, advanced liver disease, or chronic inflammatory disease
- Active malignancy
- Physical limitations preventing full participation in exercise, including severe musculoskeletal disorders or major orthopedic or neurological comorbidities
- Body mass index greater than 35 kg/m²
- History of orthopedic surgery within the previous 6 months
- Failure to comply with exercise testing or training procedures, or attendance of less than 80% of the rehabilitation program
- Use of medications known to directly alter miRNA expression, such as certain immunosuppressive agents or chemotherapy drugs
- Known psychiatric disorder
- Presence of a permanent cardiac pacemaker
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Personalized Cardiac Rehabilitation Group
Participants will undergo a structured, individualized cardiac rehabilitation program lasting 6-8 weeks. Exercise intensity and workload will be prescribed according to each participant's baseline cardiopulmonary exercise test results, including peak oxygen uptake and maximal workload. The rehabilitation program will be tailored to the participant's clinical status and exercise capacity. Clinical assessments, cardiopulmonary exercise testing, and blood sampling for miRNA and biochemical biomarker analyses will be performed before and after completion of the rehabilitation program. |
Participants will receive a structured, individualized cardiac rehabilitation program consisting of 30 supervised aerobic exercise sessions performed on a cycle ergometer. Each session will last approximately 45-60 minutes and will include a 5-10-minute low-intensity warm-up, an individualized aerobic exercise phase, and a gradual cool-down period. Exercise intensity will be prescribed according to baseline cardiopulmonary exercise testing and maximal exercise capacity. Training intensity will begin at approximately 40-50% of VO₂max, progress to 60-70% of VO₂max corresponding to a Borg Rating of Perceived Exertion of approximately 12-15, and may reach approximately 80% of VO₂max when clinically appropriate and well tolerated. Exercise workload will be individualized based on the maximal workload achieved during baseline cardiopulmonary exercise testing. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in miRNA Expression Levels
기간: Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
Changes in the expression levels of miR-21, miR-126, miR-92a, miR-1, miR-155, and miR-133a will be assessed using quantitative real-time polymerase chain reaction (qRT-PCR) before and after completion of the cardiac rehabilitation program. |
Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
|
Change in Inflammatory, Cardiac, and Oxidative Stress Biomarkers
기간: Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
Changes in circulating levels of NT-proBNP, troponins, hs-CRP, IL-6, TNF-α, ST2, semaphorins, MDA, ADMA, and eNOS will be assessed before and after the cardiac rehabilitation program. |
Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in Peak Oxygen Uptake (VO₂max)
기간: Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
Peak oxygen uptake will be assessed using cardiopulmonary exercise testing (CPET) performed on a cycle ergometer. VO₂max will be recorded in mL/kg/min as an indicator of maximal aerobic exercise capacity. |
Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
|
Change in Maximum Exercise Workload
기간: Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
Maximum exercise workload achieved during cardiopulmonary exercise testing will be recorded in watts. |
Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
|
Change in Six-Minute Walk Test Distance
기간: Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
Functional exercise capacity will be assessed using the Six-Minute Walk Test. Participants will be instructed to walk as far as possible without running along a 30-meter corridor for six minutes. The total distance walked will be recorded in meters. |
Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
|
Change in Resting Heart Rate
기간: Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
Resting heart rate will be measured before cardiopulmonary exercise testing and recorded in beats per minute. |
Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
|
Change in Maximum Heart Rate
기간: Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
Maximum heart rate achieved during cardiopulmonary exercise testing will be recorded in beats per minute. |
Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
|
Change in Health-Related Quality of Life
기간: Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
Health-related quality of life will be assessed using the 36-Item Short Form Health Survey (SF-36) before and after the cardiac rehabilitation program. |
Baseline and immediately after completion of the 6-8-week cardiac rehabilitation program
|
공동 작업자 및 조사자
수사관
수사관
- 연구 책임자: Vural KAVUNCU, Prof. Dr., Kutahya Health Sciences University
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- KSBÜ-CR-miRNA-
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
"Individual participant data will not be shared because the study includes genetic and biomarker data that may raise privacy and confidentiality concerns."
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .